Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 58 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 8r2i:A (2.9) BS01 peptide 1.10.3.9 GO:0005506 ... P07753 38322422
    2 8r2i:A (2.9) BS02 FE2 1.10.3.9 GO:0005506 ... P07753 38322422
    3 8r2i:A (2.9) BS03 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    4 8r2i:A (2.9) BS04 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    5 8r2i:A (2.9) BS05 PHO 1.10.3.9 GO:0005506 ... P07753 38322422
    6 8r2i:A (2.9) BS06 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    7 8r2i:A (2.9) BS07 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    8 8r2i:A (2.9) BS08 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    9 8r2i:A (2.9) BS09 PHO 1.10.3.9 GO:0005506 ... P07753 38322422
    10 8r2i:A (2.9) BS10 CLA 1.10.3.9 GO:0005506 ... P07753 38322422
    11 8r2i:B (2.9) BS01 CLA ? GO:0009507 ... P37255 38322422
    12 8r2i:B (2.9) BS02 CLA ? GO:0009507 ... P37255 38322422
    13 8r2i:B (2.9) BS03 CLA ? GO:0009507 ... P37255 38322422
    14 8r2i:B (2.9) BS04 CLA ? GO:0009507 ... P37255 38322422
    15 8r2i:B (2.9) BS05 CLA ? GO:0009507 ... P37255 38322422
    16 8r2i:B (2.9) BS06 CLA ? GO:0009507 ... P37255 38322422
    17 8r2i:B (2.9) BS07 CLA ? GO:0009507 ... P37255 38322422
    18 8r2i:B (2.9) BS08 CLA ? GO:0009507 ... P37255 38322422
    19 8r2i:B (2.9) BS09 CLA ? GO:0009507 ... P37255 38322422
    20 8r2i:B (2.9) BS10 CLA ? GO:0009507 ... P37255 38322422
    21 8r2i:B (2.9) BS11 CLA ? GO:0009507 ... P37255 38322422
    22 8r2i:B (2.9) BS12 CLA ? GO:0009507 ... P37255 38322422
    23 8r2i:B (2.9) BS13 CLA ? GO:0009507 ... P37255 38322422
    24 8r2i:B (2.9) BS14 CLA ? GO:0009507 ... P37255 38322422
    25 8r2i:B (2.9) BS15 CLA ? GO:0009507 ... P37255 38322422
    26 8r2i:B (2.9) BS16 CLA ? GO:0009507 ... P37255 38322422
    27 8r2i:C (2.9) BS01 peptide ? GO:0005737 ... P10898 38322422
    28 8r2i:C (2.9) BS02 CLA ? GO:0005737 ... P10898 38322422
    29 8r2i:C (2.9) BS03 CLA ? GO:0005737 ... P10898 38322422
    30 8r2i:C (2.9) BS04 CLA ? GO:0005737 ... P10898 38322422
    31 8r2i:C (2.9) BS05 CLA ? GO:0005737 ... P10898 38322422
    32 8r2i:C (2.9) BS06 CLA ? GO:0005737 ... P10898 38322422
    33 8r2i:C (2.9) BS07 CLA ? GO:0005737 ... P10898 38322422
    34 8r2i:C (2.9) BS08 CLA ? GO:0005737 ... P10898 38322422
    35 8r2i:C (2.9) BS09 CLA ? GO:0005737 ... P10898 38322422
    36 8r2i:C (2.9) BS10 CLA ? GO:0005737 ... P10898 38322422
    37 8r2i:C (2.9) BS11 CLA ? GO:0005737 ... P10898 38322422
    38 8r2i:C (2.9) BS12 CLA ? GO:0005737 ... P10898 38322422
    39 8r2i:C (2.9) BS13 CLA ? GO:0005737 ... P10898 38322422
    40 8r2i:C (2.9) BS14 CLA ? GO:0005737 ... P10898 38322422
    41 8r2i:D (2.9) BS01 FE2 1.10.3.9 GO:0005506 ... P06007 38322422
    42 8r2i:D (2.9) BS02 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    43 8r2i:D (2.9) BS03 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    44 8r2i:D (2.9) BS04 PHO 1.10.3.9 GO:0005506 ... P06007 38322422
    45 8r2i:D (2.9) BS05 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    46 8r2i:D (2.9) BS06 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    47 8r2i:D (2.9) BS07 PHO 1.10.3.9 GO:0005506 ... P06007 38322422
    48 8r2i:D (2.9) BS08 BCT 1.10.3.9 GO:0005506 ... P06007 38322422
    49 8r2i:D (2.9) BS09 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    50 8r2i:D (2.9) BS10 CLA 1.10.3.9 GO:0005506 ... P06007 38322422
    51 8r2i:E (2.9) BS01 HEM ? GO:0005506 ... P48268 38322422
    52 8r2i:F (2.9) BS01 HEM ? GO:0009523 ... Q08363 38322422
    53 8r2i:H (2.9) BS01 CLA ? GO:0009523 ... P22666 38322422
    54 8r2i:H (2.9) BS02 CLA ? GO:0009523 ... P22666 38322422
    55 8r2i:H (2.9) BS03 CLA ? GO:0009523 ... P22666 38322422
    56 8r2i:H (2.9) BS04 CLA ? GO:0009523 ... P22666 38322422
    57 8r2i:H (2.9) BS05 CLA ? GO:0009523 ... P22666 38322422
    58 8r2i:K (2.9) BS01 CLA ? GO:0009523 ... P18263 38322422
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218